kohlpharma GmbH Sustainability Profile
Kohlpharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2004, the company has established itself as a trusted provider of high-quality generic medications and innovative healthcare solutions. Kohlpharma's core offerings include a diverse range of pharmaceuticals, particularly in the areas of pain management, oncology, and cardiology. Their commitment to quality and affordability sets them apart in a competitive market. With a strong focus on research and development, Kohlpharma has achieved significant milestones, including numerous product launches that have enhanced patient care. The company is recognised for its dedication to excellence, positioning it as a leader in the generic drug sector.
DitchCarbon Score
How does kohlpharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
kohlpharma GmbH's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
kohlpharma GmbH's reported carbon emissions
As of the latest available data, kohlpharma GmbH does not report any specific carbon emissions figures, indicating a lack of disclosed emissions data. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets (SBTi) or other climate pledges. This absence of data suggests that kohlpharma GmbH may still be in the early stages of developing a comprehensive climate strategy or reporting framework. Given the increasing importance of sustainability in the pharmaceutical industry, kohlpharma GmbH may benefit from establishing clear emissions reduction targets and participating in recognised climate initiatives to enhance its environmental accountability and performance.
How Carbon Intensive is kohlpharma GmbH's Industry?
How Carbon Intensive is kohlpharma GmbH's Location?
kohlpharma GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
kohlpharma GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Aca MÜLler Adag Pharma Aktiengesellschaft
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.